August 31, 2015 4:51 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top drug manufacturers-other stocks on the NASDAQ in terms of profit margin.The trailing-twelve-month profit margin at
Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) is 20.10 percent. Sucampo Pharmaceuticals' PEG ratio is 3.75.The trailing-twelve-month profit margin at
Depomed Inc (NASDAQ: DEPO) is 18.20 percent. DEPO's ROE for the same period is 20.30 percent.The trailing-twelve-month profit margin at
United Therapeutics Corporation (NASDAQ: UTHR) is 12.80 percent. United Therapeutics' EPS for the same period is $3.19.The trailing-twelve-month profit margin at
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) is 11.10 percent. SciClone Pharmaceuticals' revenue for the same period is $147.20 million.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.